Zerbaxa

Active Ingredient(s): Ceftolozane + Tazobactam
FDA Approved: * December 19, 2014
Pharm Company: * CUBIST PHARMS INC
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Zerbaxa Overview

Ceftolozane is a novel cephalosporin antibiotic, developed for the treatment of infections with gram-negative bacteria that have become resistant to conventional antibiotics.[1] It was studied for urinary tract infections, intra-abdominal infections and ventilator-associated bacterial pneumonia. Ceftolozane is combined with the β-lactamase inhibitor tazobactam, which protects ceftolozane from degradation.[2][3][4][5&...

Read more Zerbaxa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ceftolozane

Recent Zerbaxa Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Zerbaxa: (1 result)

Sorted by National Drug Code

• 67919-030 Zerbaxa Intravenous Injection, Powder, Lyophilized, for Solution by Cubist Pharmaceuticals, Inc.

Drugs with one or more similar ingredients: (3 results)

• CEFTOLOZANE + TAZOBACTAM
• PIPERACILLIN + TAZOBACTAM
• ZOSYN Piperacillin + Tazobactam2 discussions